Definitive Tumor Resection after Myeloablative High Dose Chemotherapy Is a Feasible and Effective Option in the Multimodal Treatment of High-Risk Neuroblastoma: A Single Institution Experience.
J Pediatr Surg
; 55(8): 1655-1659, 2020 Aug.
Article
in En
| MEDLINE
| ID: mdl-31575417
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neuroblastoma
Type of study:
Etiology_studies
/
Guideline
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
J Pediatr Surg
Year:
2020
Type:
Article